Genipin crosslinking reduced the immunogenicity of xenogeneic decellularized porcine whole-liver matrices through regulation of immune cell proliferation and polarization

Decellularized xenogeneic whole-liver matrices are plausible biomedical materials for the bioengineering of liver transplantation. A common method to reduce the inflammatory potential of xenogeneic matrices is crosslinking. Nevertheless, a comprehensive analysis of the immunogenic features of cross-linked decellularized tissue is still lacking. We aimed to reduce the immunogenicity of decellularized porcine whole-liver matrix through crosslinking with glutaraldehyde or genipin, a new natural agent, and investigated the mechanism of the immune-mediated responses. The histologic assessment of the host’s immune reaction activated in response to these scaffolds, as well as the M1/M2 phenotypic polarization profile of macrophages, was studied in vivo. The genipin-fixed scaffold elicited a predominantly M2 phenotype response, while the glutaraldehyde-fixed scaffold resulted in disrupted host tissue remodeling and a mixed macrophage polarization profile. The specific subsets of immune cells involved in the responses to the scaffolds were identified in vitro. Crosslinking alleviated the host response by reducing the proliferation of lymphocytes and their subsets, accompanied by a decreased release of both Th1 and Th2 cytokines. Therefore, we conclude that the natural genipin crosslinking could lower the immunogenic potential of xenogeneic decellularized whole-liver scaffolds.

[1]  S. Badylak,et al.  Macrophage phenotype as a determinant of biologic scaffold remodeling. , 2008, Tissue engineering. Part A.

[2]  Martina Schleicher,et al.  Human immune responses to porcine xenogeneic matrices and their extracellular matrix constituents in vitro. , 2010, Biomaterials.

[3]  Stephen F Badylak,et al.  Immune response to biologic scaffold materials. , 2008, Seminars in Immunology.

[4]  A. Dardik,et al.  A decade of experience with the glutaraldehyde-tanned human umbilical cord vein graft for revascularization of the lower limb. , 1988, Journal of vascular surgery.

[5]  H. Sung,et al.  Pro-angiogenic and anti-inflammatory regulation by functional peptides loaded in polymeric implants for soft tissue regeneration. , 2013, Tissue engineering. Part A.

[6]  Costantino Del Gaudio,et al.  Biomechanical and angiogenic properties of tissue-engineered rat trachea using genipin cross-linked decellularized tissue. , 2012, Biomaterials.

[7]  S. Hsu,et al.  Biocompatibility and biodegradation of a bone composite containing tricalcium phosphate and genipin crosslinked gelatin. , 2004, Journal of biomedical materials research. Part A.

[8]  James M. Anderson,et al.  Foreign body reaction to biomaterials. , 2008, Seminars in immunology.

[9]  H. Sung,et al.  Biocompatibility study of a biological tissue fixed with a naturally occurring crosslinking reagent. , 1998, Journal of biomedical materials research.

[10]  A. Chambers,et al.  Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth. , 2010, European journal of cancer.

[11]  George P McCabe,et al.  Extracellular matrix bioscaffolds for orthopaedic applications. A comparative histologic study. , 2006, The Journal of bone and joint surgery. American volume.

[12]  K. Marra,et al.  Controlled in vivo degradation of genipin crosslinked polyethylene glycol hydrogels within osteochondral defects. , 2006, Tissue engineering.

[13]  F. Richards,et al.  Glutaraldehyde as a protein cross-linking reagent , 1968 .

[14]  E Wolner,et al.  Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients. , 2003, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[15]  E. Wolner,et al.  Granulocyte-based immune response against decellularized or glutaraldehyde cross-linked vascular tissue. , 2006, Biomaterials.

[16]  L. Nicholson,et al.  Modulation of the immune response by extracellular matrix proteins , 2006, Archivum Immunologiae et Therapiae Experimentalis.

[17]  R. Grant.  ESTIMATION OF HYDROXYPROLINE BY THE AUTOANALYSER. , 1964, Journal of clinical pathology.

[18]  A. Krensky,et al.  New insights into mechanisms of allograft rejection. , 1997, The American journal of the medical sciences.

[19]  D. Cooper,et al.  Reducing Gal expression on the pig organ – a retrospective review , 2005, Xenotransplantation.

[20]  B. Hinz.  Formation and function of the myofibroblast during tissue repair. , 2007, The Journal of investigative dermatology.

[21]  K. Shakesheff,et al.  Scaffolds for liver tissue engineering , 2006, Expert review of medical devices.

[22]  C. Morimoto,et al.  Activation of CD4 cells by fibronectin and anti-CD3 antibody. A synergistic effect mediated by the VLA-5 fibronectin receptor complex , 1989, The Journal of experimental medicine.

[23]  Hsing-Wen Sung,et al.  Crosslinking of biological tissues using genipin and/or carbodiimide. , 2003, Journal of biomedical materials research. Part A.

[24]  Kerry A. Daly,et al.  Macrophage phenotype as a predictor of constructive remodeling following the implantation of biologically derived surgical mesh materials. , 2012, Acta biomaterialia.

[25]  Frederick J Schoen,et al.  Calcification of tissue heart valve substitutes: progress toward understanding and prevention. , 2005, The Annals of thoracic surgery.

[26]  Xiujuan Wu,et al.  Method for perfusion decellularization of porcine whole liver and kidney for use as a scaffold for clinical‐scale bioengineering engrafts , 2015, Xenotransplantation.

[27]  B. Petersen,et al.  Immunogenicity of decellularized porcine liver for bioengineered hepatic tissue. , 2013, The American journal of pathology.

[28]  Ellen P. Brennan-Pierce,et al.  Interactions of U937 macrophage-like cells with decellularized pericardial matrix materials: influence of crosslinking treatment. , 2013, Acta biomaterialia.

[29]  Jacqueline A. Jones,et al.  Phenotypic dichotomies in the foreign body reaction. , 2007, Biomaterials.

[30]  F. Costa,et al.  Evaluation of humoral immune response to donor HLA after implantation of cellularized versus decellularized human heart valve allografts. , 2012, Tissue antigens.

[31]  Kristi Kincaid,et al.  M-1/M-2 Macrophages and the Th1/Th2 Paradigm1 , 2000, The Journal of Immunology.

[32]  S. Badylak,et al.  The Th2-restricted immune response to xenogeneic small intestinal submucosa does not influence systemic protective immunity to viral and bacterial pathogens. , 2002, Tissue engineering.

[33]  D. Courtman,et al.  The role of crosslinking in modification of the immune response elicited against xenogenic vascular acellular matrices. , 2001, Journal of biomedical materials research.

[34]  D. Speer,et al.  Biological effects of residual glutaraldehyde in glutaraldehyde-tanned collagen biomaterials. , 1980, Journal of biomedical materials research.

[35]  Ernst Wolner,et al.  Tissue Engineering of Heart Valves: Decellularized Porcine and Human Valve Scaffolds Differ Importantly in Residual Potential to Attract Monocytic Cells , 2005, Circulation.

[36]  G. Korbutt,et al.  Glutaraldehyde-Fixed Bioprosthetic Heart Valve Conduits Calcify and Fail From Xenograft Rejection , 2006, Circulation.

[37]  R. Hershkoviz,et al.  Interactions of migrating T lymphocytes, inflammatory mediators, and the extracellular matrix. , 1995, Critical reviews in immunology.

[38]  Stephen F Badylak,et al.  Decellularization of tissues and organs. , 2006, Biomaterials.

[39]  T. Jiang,et al.  Preparation and characterization of genipin-crosslinked rat acellular spinal cord scaffolds. , 2013, Materials science & engineering. C, Materials for biological applications.

[40]  H. Sung,et al.  In vitro evaluation of cytotoxicity of a naturally occurring cross-linking reagent for biological tissue fixation. , 1999, Journal of biomaterials science. Polymer edition.

[41]  A. Greenburg,et al.  Extracellular matrix bioscaffolds for orthopaedic applications. , 2010, The Journal of bone and joint surgery. American volume.

[42]  H. Sung,et al.  In vivo evaluation of cellular and acellular bovine pericardia fixed with a naturally occurring crosslinking agent (genipin). , 2002, Biomaterials.

[43]  S. Badylak,et al.  XENOGENEIC EXTRACELLULAR MATRIX GRAFTS ELICIT A TH2-RESTRICTED IMMUNE RESPONSE1 , 2001, Transplantation.

[44]  Seok-Ho Hong,et al.  Preparation of immunogen-reduced and biocompatible extracellular matrices from porcine liver. , 2013, Journal of bioscience and bioengineering.

[45]  A. Dietz,et al.  Serum-Free Medium and Mesenchymal Stromal Cells Enhance Functionality and Stabilize Integrity of Rat Hepatocyte Spheroids , 2013, Cell transplantation.

[46]  Ricardo Londono,et al.  Consequences of ineffective decellularization of biologic scaffolds on the host response. , 2012, Biomaterials.

[47]  F. Richards,et al.  Glutaraldehyde as a protein cross-linkage reagent. , 1968, Journal of molecular biology.

[48]  Stephen F Badylak,et al.  An overview of tissue and whole organ decellularization processes. , 2011, Biomaterials.

[49]  C. Schmidt,et al.  Acellular vascular tissues: natural biomaterials for tissue repair and tissue engineering. , 2000, Biomaterials.